GRAFTASSURE Trademark
Trademark Overview
On Thursday, October 5, 2023, a trademark application was filed for GRAFTASSURE with the United States Patent and Trademark Office. The USPTO has given the GRAFTASSURE trademark a serial number of 98211361. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 20, 2025. This trademark is owned by Oncocyte Corporation. The GRAFTASSURE trademark is filed in the Pharmaceutical Products category with the following description:
Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation
General Information
| Serial Number | 98211361 |
| Word Mark | GRAFTASSURE |
| Filing Date | Thursday, October 5, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, February 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Oncocyte Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Monday, October 9, 2023 | NEW APPLICATION ENTERED |
| Saturday, October 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 16, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, April 24, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, May 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, July 8, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 23, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, February 20, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, August 8, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Thursday, February 20, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 20, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, May 20, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, February 20, 2025 | NON-FINAL ACTION E-MAILED |
